JP2020508984A5 - - Google Patents

Download PDF

Info

Publication number
JP2020508984A5
JP2020508984A5 JP2019543282A JP2019543282A JP2020508984A5 JP 2020508984 A5 JP2020508984 A5 JP 2020508984A5 JP 2019543282 A JP2019543282 A JP 2019543282A JP 2019543282 A JP2019543282 A JP 2019543282A JP 2020508984 A5 JP2020508984 A5 JP 2020508984A5
Authority
JP
Japan
Prior art keywords
collagen
seq
binding
polypeptide
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019543282A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020508984A (ja
JP7397440B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/017665 external-priority patent/WO2018148573A1/en
Publication of JP2020508984A publication Critical patent/JP2020508984A/ja
Publication of JP2020508984A5 publication Critical patent/JP2020508984A5/ja
Priority to JP2023044982A priority Critical patent/JP7682503B2/ja
Application granted granted Critical
Publication of JP7397440B2 publication Critical patent/JP7397440B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019543282A 2017-02-10 2018-02-09 コラーゲン結合薬剤組成物およびその使用方法 Active JP7397440B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023044982A JP7682503B2 (ja) 2017-02-10 2023-03-22 コラーゲン結合薬剤組成物およびその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762457410P 2017-02-10 2017-02-10
US62/457,410 2017-02-10
PCT/US2018/017665 WO2018148573A1 (en) 2017-02-10 2018-02-09 Collagen-binding agent compositions and methods of using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023044982A Division JP7682503B2 (ja) 2017-02-10 2023-03-22 コラーゲン結合薬剤組成物およびその使用方法

Publications (3)

Publication Number Publication Date
JP2020508984A JP2020508984A (ja) 2020-03-26
JP2020508984A5 true JP2020508984A5 (enExample) 2021-03-25
JP7397440B2 JP7397440B2 (ja) 2023-12-13

Family

ID=63107889

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019543282A Active JP7397440B2 (ja) 2017-02-10 2018-02-09 コラーゲン結合薬剤組成物およびその使用方法
JP2023044982A Active JP7682503B2 (ja) 2017-02-10 2023-03-22 コラーゲン結合薬剤組成物およびその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023044982A Active JP7682503B2 (ja) 2017-02-10 2023-03-22 コラーゲン結合薬剤組成物およびその使用方法

Country Status (3)

Country Link
US (1) US11624060B2 (enExample)
JP (2) JP7397440B2 (enExample)
WO (1) WO2018148573A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3391899B1 (en) * 2011-12-14 2020-07-15 The Board of Trustees of the University of Arkansas Delivery of therapeutic agents by a collagen binding protein
WO2018148573A1 (en) * 2017-02-10 2018-08-16 The Board Of Trustees Of The University Of Arkansas Collagen-binding agent compositions and methods of using the same
US12403179B2 (en) * 2021-02-18 2025-09-02 The Board Of Trustees Of The University Of Arkansas Release of growth factors at wound healing stages

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8516421D0 (en) 1985-06-28 1985-07-31 Biotechnology Interface Ltd Fibronectins
ATE209887T1 (de) 1993-04-02 2001-12-15 Anticancer Inc Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel
AU3819497A (en) 1996-07-31 1998-02-20 General Hospital Corporation, The Novel parathyroid hormone-related peptide analogs
US20100267012A1 (en) 1997-11-04 2010-10-21 Bergeron Michel G Highly conserved genes and their use to generate probes and primers for detection of microorganisms
US6387663B1 (en) 1998-07-31 2002-05-14 University Of Southern California Targeting pharmaceutical agents to injured tissues
US7601685B2 (en) 1998-08-27 2009-10-13 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
EP1151116A1 (en) 1999-02-19 2001-11-07 Terumo Kabushiki Kaisha Collagen-binding physiologically active polypeptide
US20020102709A1 (en) 1999-02-19 2002-08-01 Tetsuya Ishikawa Collagen-binding physiologically active polypeptide
US6908994B1 (en) 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
US7396664B2 (en) 1999-06-08 2008-07-08 Regeneron Pharmaceuticals, Inc. VEGF-binding fusion proteins and nucleic acids encoding the same
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US20050124537A1 (en) 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
EP1314780A4 (en) 2000-08-15 2004-07-28 Terumo Corp Collagen-binding hybrid polypeptides
JP2002058485A (ja) 2000-08-16 2002-02-26 Terumo Corp コラーゲン結合性を有する骨形成促進融合蛋白質
ES2301697T3 (es) 2001-12-18 2008-07-01 Eidgenossisch Technische Hochschule Zurich Matrices de proteina modificada con factor de crecimiento para ingenieria de tejidos.
JP2003284553A (ja) * 2002-03-28 2003-10-07 Seikagaku Kogyo Co Ltd 生理活性タンパク質
WO2004011484A2 (en) 2002-07-25 2004-02-05 The General Hospital Corporation Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
AU2003203316B2 (en) 2003-02-13 2007-01-11 Synthes Gmbh Injectable bone-replacement mixture
US20040220094A1 (en) 2003-05-01 2004-11-04 Skinner Keith K. Inverse agonist and agonist peptides that stimulate/inhibit hair growth
WO2005046798A1 (en) 2003-11-12 2005-05-26 Nps Allelix Corp. Treatment of bone loss utilizing full length parathyroid hormone
EP1557176A1 (en) 2004-01-26 2005-07-27 Ferring B.V. Treatment of bone metastases by means of PTH receptor agonists
US8030448B2 (en) 2004-02-16 2011-10-04 Techno Network Shikoku Co., Ltd. Polypeptide having collagen-like structure
PL2348114T3 (pl) 2004-04-21 2019-08-30 Alexion Pharmaceuticals, Inc. Koniugaty do dostarczania do kości i sposób ich wykorzystania do nakierowywania białek na kość
WO2006073711A2 (en) 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
US8802396B2 (en) 2005-12-26 2014-08-12 Yantai Zhenghai Bio-Technology Co., Ltd. Activated collagen scaffold materials and their special fused active restoration factors
US8987200B2 (en) 2006-11-16 2015-03-24 Kai Pharmaceuticals, Inc. Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders
WO2008101406A1 (en) 2007-02-14 2008-08-28 Yolare Dermaceuticals, Llc Modified mutant collagenase and it's use in fat melting and in scar reduction
ES2675174T3 (es) 2007-04-09 2018-07-09 The Board Of Trustees Of The University Of Arkansas Proteínas de fusión de un dominio de enlazamiento a colágeno y hormona paratiroidea
US8486422B2 (en) 2007-07-26 2013-07-16 Allergan, Inc. Methods of activating clostridial toxins
US20100159564A1 (en) 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
JP2010172247A (ja) 2009-01-29 2010-08-12 Kitasato Institute 積層型高密度培養人工組織の製造方法及び積層型高密度培養人工組織
US10046040B2 (en) 2009-11-16 2018-08-14 University Of Maryland, Baltimore Multivalent live vector vaccine against Clostridium difficile-associated disease
JPWO2011142425A1 (ja) 2010-05-12 2013-07-22 国立大学法人 香川大学 上皮層含有組織の再生材および再生評価方法
ES2385239B1 (es) 2010-09-30 2013-06-19 Proteos Biotech S.L.U. Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno.
CN103562719B (zh) 2011-03-16 2016-01-13 国立大学法人东北大学 生物体组织分析用探针及其使用方法
EP2708246B1 (en) 2011-05-13 2017-11-01 School Juridical Person Kitasato Institute Growth factor anchoring type bone graft material, method for producing growth factor anchoring type bone graft material, kit for producing growth factor anchoring type bone graft material.
WO2013120060A1 (en) 2012-02-09 2013-08-15 The Board Of Trustees Of The University Of Arkansas Delivery of therapeutic agents by a collagen binding protein
EP3391899B1 (en) * 2011-12-14 2020-07-15 The Board of Trustees of the University of Arkansas Delivery of therapeutic agents by a collagen binding protein
EP4276180B1 (en) 2012-01-12 2026-04-22 Endo Biologics Limited Clostridium histolyticum enzyme
WO2013120030A1 (en) 2012-02-08 2013-08-15 Shining Golden Yida Welding & Cutting Machinery Manufacture Ltd. Rotary vane air motor with improved vanes and other improvements
US9962428B2 (en) 2012-12-21 2018-05-08 National University Corporation Nagoya University Composition having tissue-repairing activity, and use therefor
EP3048904A2 (en) 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
US9539363B2 (en) 2014-04-24 2017-01-10 Warsaw Orthopedic, Inc. Collagen matrix
US20180140742A1 (en) 2014-10-16 2018-05-24 School Juridical Person Kitasato Institute Graft material for nerve regeneration, method for producing graft material for nerve regeneration, and kit for producing graft material for nerve regeneration
EP3112474A1 (en) 2015-06-29 2017-01-04 Evonik Degussa GmbH Method of detecting avian necrotic enteritis
RS64440B1 (sr) 2016-09-29 2023-09-29 Ascendis Pharma Bone Diseases As Režim doziranja za pth jedinjenje sa kontrolisanim oslobađanjem
WO2018148573A1 (en) * 2017-02-10 2018-08-16 The Board Of Trustees Of The University Of Arkansas Collagen-binding agent compositions and methods of using the same
US20190248881A1 (en) 2017-12-04 2019-08-15 Precithera, Inc. TGF-ß RECEPTOR FUSION PROTEINS AND OTHER TGF-ß ANTAGONISTS FOR REDUCING TGF-ß SIGNALING
EP3743081A4 (en) 2018-01-23 2021-12-01 New York University SPECIFIC ANTIBODIES OF THE DELTA 1 CHAIN OF THE T-LYMPHOCYTE RECEPTOR
EP3762429A4 (en) 2018-03-09 2022-03-23 University of Pittsburgh - Of the Commonwealth System of Higher Education DELIVERY OF BIOLOGICAL AGENTS TO TISSUE

Similar Documents

Publication Publication Date Title
Rothe et al. Growth factors: their biology and promise in dermatologic diseases and tissue repair
RU2468080C2 (ru) Новый класс терапевтических белковых молекул
Thomas et al. Fibroblast growth factors: broad spectrum mitogens with potent angiogenic activity
CN102718858B (zh) 胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用
JP4319227B2 (ja) マクロファージ炎症蛋白変種をコードするポリヌクレオチド
US20170335311A1 (en) Chimeric protein
JP2018104461A5 (enExample)
JP2015513312A5 (enExample)
JPH0699322B2 (ja) 傷の治癒
CA2223701A1 (en) Fgf9 as a specific ligand for fgfr3
MXPA01007956A (es) Polipeptido antimicrobiano/neutralizador de endotoxina.
US20070021342A1 (en) Wound Healing
JPH03500782A (ja) 創傷の治癒
JP2000506894A (ja) 中枢神経系の虚血または外傷の機能的回復を増大させる方法
RU99107759A (ru) Применение антагонистов лептина для лечения резистентности к инсулину при диабете ii типа
JP2009515529A5 (enExample)
JP2005506275A5 (enExample)
CN1643140A (zh) 生长因子和蛋白酶的组合
US20150313967A1 (en) Methods and Agents for Wound Healing
JPH0768139B2 (ja) 創傷の治癒
WO2021087561A1 (en) Cytokine or growth factor fusion proteins
JP2023088982A (ja) コラーゲン結合薬剤組成物およびその使用方法
JP2025060836A5 (enExample)
KR19990022716A (ko) 골 자극 인자
KR20060106606A (ko) 조직재생 기능을 가지는 비활성 폴리펩티드 및 그 제조방법